![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
治疗慢性淋巴细胞白血病的当前方法和新药
Bruce D Cheson1, Jeff P Sharman2
1Center for Cancer and Blood Disorders, Bethesda, MD.
JCO oncology practice
|June 7, 2024
概括
慢性淋巴细胞白血病 (CLL) 治疗已经从化疗免疫疗法转向向疗法. 新的布鲁顿氨酸激酶抑制剂 (BTKis) 和BCL-2抑制剂提供了更好的疗效和安全性,提高了患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性淋巴细胞白血病 (CLL) 治疗历史上一直依赖于化疗免疫疗法 (CIT).
- 最近的进展引入了向疗法和生物药物,提供了新的治疗途径.
- 临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床临床
研究的目的:
- 审查从CIT到现代向和生物方法的CLL治疗的演变.
- 突出新药的疗效和安全性,包括BTK抑制剂和BCL-2抑制剂.
- 讨论新兴的治疗策略及其对CLL患者结果的潜在影响.
主要方法:
- 随机临床试验的综述,比较不同的CLL治疗方式.
- 对共价和非共价BTK抑制剂 (BTKis) 的疗效和安全数据的分析.
- 评估BCL-2抑制剂 (venetoclax) 的疗效,通常与CD20抗体结合使用.
- 探索新的治疗方法,如BTK降解剂,双特异性抗体和CAR-T细胞疗法.
主要成果:
- 随机试验表明共价BTK抑制剂 (cBTKis) 对CLL优于CIT.
- 第二代cBTKs (acalabrutinib,zanubrutinib) 显示出比ibrutinib更好的疗效/安全性.
- 非共价BTKi (pirtobrutinib) 在cBTKi失效后表现出活性,耐受性良好.
- 威尼托克拉克斯加上奥比努图祖马布产生了高效率,在许多患者中实现了不可检测的最小残留疾病.
结论:
- 化疗免疫疗法 (CIT) 被认为是CLL的古老治疗方法.
- 目前的向疗法,包括BTK抑制剂和BCL-2抑制剂,显著改善了CLL患者的治疗结果.
- 未来的方法,如BTK降解剂,双特异性抗体和CAR-T细胞疗法,有望进一步推进CLL治疗.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K